{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-012414","form_type":"8-K","ticker":"PRPH","cik":"0000868278","company_name":"ProPhase Labs, Inc.","filed_at":"2025-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.527659+00:00","generated_at":"2026-05-17T09:35:39.467078+00:00","sec_items":["1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ProPhase Labs terminates $7.7M equity line with Keystone Capital Partners","bullets":["Terminated Common Stock Purchase Agreement with Keystone Capital Partners effective August 28, 2025.","Agreement allowed sale of up to ~$7.7M of common stock at Company’s option.","Termination was at sole discretion, with no penalties or termination fees.","No other material relationships between Company and Keystone."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-012414","json":"https://secwatch.observer/filing/0001493152-25-012414.json","markdown":"https://secwatch.observer/filing/0001493152-25-012414.md","text":"https://secwatch.observer/filing/0001493152-25-012414.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/868278/000149315225012414/0001493152-25-012414-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/868278/000149315225012414/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:35:39.467078+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}